FDA supports open data to improve patient safety

The U.S. Food and Drug Administration signed a letter of support May 30 for openly sharing data through efforts such as the Patient Safety Movement Foundation’s Open Data Pledge, according to an announcement made June 27.

Advertisement

The FDA says open data engages patients in developing and evaluating medical devices, allows for the identification and prevention of adverse events and sheds light on the benefits and risks of healthcare technology. 

 Leaders in healthcare technology commit to openly sharing data when they sign the Patient Safety Movement’s Open Data Pledge. Algorithms based on the data help reduce preventable patient harm and deaths.

More articles on clinical leadership and infection control:
Viewpoint: The US must eliminate non-medical vaccine exemptions
Senators introduce bill to address high maternal and infant mortality in US: 4 things to know
CDC panel recommends HPV vaccine for some adults

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.